Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01681992 |
|---|---|
| Brief Title: | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life |
| First Submitted : | September 6, 2012 |
| First Submitted that Met QC Criteria : | September 6, 2012 |
| First Posted : | September 10, 2012 (Estimate) |
| Results First Submitted : | December 30, 2016 |
| Results First Submitted that Met QC Criteria : | July 19, 2018 |
| Results First Posted : | August 17, 2018 |
| Certification/Extension First Submitted : | April 7, 2016 |
| Certification/Extension First Submitted that Met QC Criteria : | April 7, 2016 |
| Certification/Extension First Posted : | May 4, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 15, 2020 |
| Last Update Posted : | January 7, 2021 |